68 results
6-K
EX-99.1
ENLV
Enlivex Therapeutics Ltd
29 Mar 24
Report of Foreign Private Issuer
4:30pm
740-10 “Accounting for Income Taxes”, which requires the use of the liability method of accounting for income taxes, whereby deferred tax asset … and liability account balances are determined based on the differences between financial reporting and tax bases of assets and liabilities and are measured
6-K
EX-99.1
ENLV
Enlivex Therapeutics Ltd
13 Sep 23
Notice of Annual General Meeting of Shareholders
4:42pm
), are intended to be granted pursuant to the capital gains track of Section 102 of the Israeli Income Tax Ordinance [New Version] 5721-1961.
Each of our … agreements to be entered into with each of them, and shall be granted pursuant to the capital gains track of Section 102 of the Israeli Income Tax
6-K
EX-99.1
uilo 4ek01
31 Mar 23
Report of Foreign Private Issuer
4:30pm
6-K
EX-10.1
qcsgygxxt
30 Dec 22
Report of Foreign Private Issuer
4:02pm
424B5
1gd o1py3z
30 Dec 22
Prospectus supplement for primary offering
4:01pm
6-K
EX-99.1
yeywzjp74qnu7w8vh1a
5 Oct 22
Notice of Annual General Meeting of Shareholders
3:00pm
F-3
nrql50i3jg 0qp52egs
29 Apr 22
Shelf registration (foreign)
8:14am
6-K
EX-99.1
y3b1pn49
30 Sep 21
Annual and Extraordinary General Meeting of Shareholders
8:01am
6-K
EX-10.1
djcp2yoy80c50l6gvxv
12 Feb 21
Enlivex Announces Closing of Previously Announced Bought Deal Offering of Approximately $46.0 Million Ordinary Shares
5:17pm
6-K
EX-1.1
le0r80u
12 Feb 21
Enlivex Announces Closing of Previously Announced Bought Deal Offering of Approximately $46.0 Million Ordinary Shares
5:17pm
424B5
20ox78rxo0xozns
10 Feb 21
Prospectus supplement for primary offering
5:22pm
424B5
7ccmg8e8tna 2aya
9 Feb 21
Prospectus supplement for primary offering
4:56pm
6-K
EX-99.2
nd6vszzfz
30 Oct 20
Condensed Consolidated Financial Statements
4:30pm
6-K
EX-10.1
8t4tla1qpim wai246i
22 Oct 20
Report of Foreign Private Issuer
8:47am